MDCO Stock Chart

MEDICINES CO

 

MDCO

News

Fundamentals MDCO

Price History
Average Volume (10 day) ---
Beta - 1 Year ---
Price - 52 Week High ---
Price - 52 Week Low ---
Valuation
Enterprise Value/EBITDA, TTM ---
Enterprise Value, FQ ---
Market Cap - Basic ---
Number of Employees ---
Number of Shareholders ---
Price/Earnings, TTM ---
Price/Revenue, TTM ---
Price/Book Ratio, FY ---
Price/Sales Ratio, FY ---
Dividends
Dividends Paid, FY ---
Dividends per Share, FQ ---
Expected Annual Dividends ---
Dividends Yield ---
Margins
Net Margin, TTM ---
Gross Margin, TTM ---
Operating Margin, TTM ---
Pretax Margin, TTM ---
Balance Sheet
Cash Ratio, FY ---
Current Ratio, FQ ---
Debt to Equity, FQ ---
Net Debt, FQ ---
Quick Ratio, FQ ---
Total Assets, FQ ---
Total Debt, FQ ---
Income Statement
Basic EPS, Net Income ---
Earnings per Share, Basic, TTM ---
EBITDA, TTM ---
Gross Profit, FY ---
Last Annual EPS ---
Last Annual Revenue, FY ---
Net Income, FY ---
Total Revenue, FY ---
Free Cash Flow, TTM ---
Operating Metrics
Return on Assets, TTM ---
Return on Equity, TTM ---
Return on Invested Capital, TTM ---
Revenue per Employee, TTM ---
digiholic digiholic NWAV, D, Long ,
NWAV: NWAV descending wedge breakout possible
7 0 3
NWAV, D Long
NWAV descending wedge breakout possible

The company is opening alternative medicine clinics and an open house starts tomorrow with 2 more opening in the next month. This is teetering on a hard breakout as the volume is preceding the movement. Tomorrow will be the tell tale sign.

ParCorn ParCorn PRO AXTA, D,
AXTA: Potential Earnings Plays 2017/04/25
21 0 3
AXTA, D
Potential Earnings Plays 2017/04/25

EW (Reports 4/25/2017 AC) IVR = 75.7, Expected Move = 5.12% AXTA (Reports 4/26/2017 BM) IVR = 59.9, Expected Move = 5.00% MDCO (Reports 4/26/2017 BM) IVR = 100!!, Expected Move = 12.71% DPS (Reports 4/26/2017 BM) IVR = 67.3, Expected Move = 3.73%

StockGuild StockGuild PRO OWCP, 15, Long ,
OWCP: $OWCP Bullish Pennant Formation with Upcoming MJ Catalysts News
34 0 3
OWCP, 15 Long
$OWCP Bullish Pennant Formation with Upcoming MJ Catalysts News

ANNUAL REPORT CLARIFICATION FOR SHAREHOLDERS: 1) Page 5: Don't get confused by the OWCP already done Psoriasis study (where efficacy results are imminent) and next deeper and extended studies planned from April: "On February 1, 2017, following the very encouraging results that have been achieved at the mid-point of the Study, the Company determined to extend ...

Garry_MyT Garry_MyT PRO BEAT, D, Long ,
BEAT: BEAT
23 0 5
BEAT, D Long
BEAT

The sector of this stock is one of the most promising, in my opinion. The company is engaged in equipment for science and medicine. Good statement. The pattern for buy gives us an excuse to open a long position

Cryptocol Cryptocol MJNA, D, Long ,
MJNA: MJNA- Poised for the moon
176 0 1
MJNA, D Long
MJNA- Poised for the moon

My first idea here on trading view is probably a controversial one. I am long on MJNA with 2 entry points at 0.04 and 0.182 for a total of approx 6500 shares. MJNA is a stock that is poised for success. Even if only for the next 15-20 days. 9 states have cannabis legalization/medicinal marijuana props on the ballot which is encouraging a lot of bullish ...

itradevol itradevol MDCO, W,
MDCO: MDCO Implied Volatility Rising Ahead Of November Trial Results
4 0 1
MDCO, W
MDCO Implied Volatility Rising Ahead Of November Trial Results

MDCO Implied Volatility Rising Ahead Of November Trial Results https://marketchameleon.com/ The Medicines Company  is scheduled to release updated drug trial results for its developmental cardiovascular drug MDCO-216 in November.  Anticipation for the data is beginning to rise, and the stock has already proven susceptible to notable swings in price as a result ...

toolbox toolbox PTX, 60, Long ,
PTX: $PTX Dust has settled showing genuine opportunity
136 0 1
PTX, 60 Long
$PTX Dust has settled showing genuine opportunity

PTX has been having a bad run over the last year or two. It has been bashed and heavily shorted, the dreaded debt and SEC standards issues added to this. Recently under the new leadership of veteran Sedor, the company has restructured its operations and staffing, added new product in pediatric pain medicine, added new patent in Japan and has a number of drugs in ...

koryu koryu PRO EDIT, W, Long ,
EDIT: editas medicine crispr/cas9 investment
701 2 11
EDIT, W Long
editas medicine crispr/cas9 investment

I enter long as long term investment in CRISPR/Cas9 technology. There is still a patent battle going on, thats why there is the big dump in the chart. Buying here feels like catching the knife, so buying slowly over time.

akyong akyong GOOG, D, Long ,
GOOG: Alphabet [Google] Potentially Breaking the All Time High
56 0 1
GOOG, D Long
Alphabet [Google] Potentially Breaking the All Time High

GlaxoSmithKline and Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a new field of medicine known as bioelectronics. For Verily, the tie-up is the latest sign that Google's desire to move beyond search engines into biology and other scientific areas is gaining ...

AcornWealthCorp AcornWealthCorp PRO MDCO, D, Short ,
MDCO: MDCO - Short from 33.23
61 0 2
MDCO, D Short
MDCO - Short from 33.23

Upward channel break down in longer frame & formed a pennant now. Money-flow is moving down. We think it will decline around 30 You can check our detailed analysis on MDCO in the trading room/ Executive summery link here- http://www.screencast.com/t/albA50iuLT Time Span: 33:00” Trade Suggestion Date: 5th Jul Trade status: waiting for entry confirmation

Pdunuwila Pdunuwila FMI, D,
FMI: Foundation Medicine Inc.
16 0 0
FMI, D
Foundation Medicine Inc.

Demand zone highlighted in yellow at former resistance. Buy on a pullback to the demand zone. Entry: $18.85 Stop Loss: $18.10 Target1: $20.00

andrew.berg andrew.berg LGND, D, Long ,
LGND: Ligand Pharmaceuticals best choise in the Biopharma Industry
24 0 4
LGND, D Long
Ligand Pharmaceuticals best choise in the Biopharma Industry

Fundamentals: Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines worldwide. Ligand Pharmaceuticals has a compelling business model that offers higher than average return with lower than average risk. Ligand's P/E of 8 is cheap as I ...

KLang KLang PRO MDCO, W,
MDCO: MDCO
98 1 2
MDCO, W
MDCO

Notes on chart

KeeneOnMarket KeeneOnMarket PRO MACK, D, Long ,
MACK: Trader Profits 450% Overnight in MACK on Unusual Options Activit
469 0 1
MACK, D Long
Trader Profits 450% Overnight in MACK on Unusual Options Activit

Merrimack Pharmaceuticals, Inc. (MACK) a biopharmaceutical company is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. MACK is currently trading around $7.12 in a 52 week range of $2.05-$7.65. The company’s stock has been under performing the ...

BitcoinMedusa BitcoinMedusa TAN, 60,
TAN: Mentor Tells Me About This Week / via StockMarketMentor
147 0 1
TAN, 60
Mentor Tells Me About This Week / via StockMarketMentor

Here is the ticker list with some notes. Big trendline breaks on many of these. There is no reason to buy, but there is no reason to sell immediately at the open either. The starter pistol fires at 5:30a/est. TAN TF XME IBB XLI XHB XLB MDY IWM OIH XLV XOP XLF SPY XLE IYZ QQQ XLK XLY SMH SDY XRT XLU XLP GLD VXX This is the stock watch ...

BitcoinMedusa BitcoinMedusa AAPL, 60,
AAPL: Think Differently Might Be The Right Thing To Do
180 0 0
AAPL, 60
Think Differently Might Be The Right Thing To Do

Break above recent highs, break above prior "w" pattern, and that gap looking like a little piece of history that won't be revisited. This company is a great company period. Progressive, meaningful, well suited for un-expected advances in marketing, medicine, robotics, new communities and no one can out last its impact on education. Really no-one. Sincerely, ...

Market
Interval
Browse
Time
Author
Widgets
Ideas Scripts Chart
United States
United Kingdom
India
España
France
Italia
Polska
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Forex Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Account and Billing Sign Out